Provisional, Verified, and How Not to Over-Claim

Part of Regulatory Affairs and the Jurisdiction Map: Building and Defending a Global Position.

About 5 minutes. Free, in your language, no account needed.

Why this matters

The most damaging regulatory statements are not lies. They are true statements phrased to carry more weight than the evidence behind them, made by people who believed them.

This matters commercially as much as ethically. A large sponsor's due diligence team, a partner's regulatory director, and an inspector are all trained to find the gap between a claim and its support. Finding one does not just cost you that claim. It costs you the presumption of good faith on every other claim you made.

The grades of claim, and the language each permits

Verified. Checked against a primary source, with the source named and the date recorded. Permits: "Under the New Drugs and Clinical Trials Rules, 2019, First Schedule, verified against the published instrument in September 2026."

Inferred from a stated basis. Not checked directly, but derived from something that was, with the derivation stated. Permits: "We have not verified this jurisdiction's national instrument. It applies the international baseline, and our position assumes the baseline applies absent national modification."

Reported by a secondary source. Someone else says so. Permits: "A published country guide reports this requirement. We have not confirmed it against the instrument."

Unknown. Permits: "We do not know, and here is what it would take to find out."

The fourth is a legitimate professional answer and is routinely treated as a failure. It is not. An organization whose people cannot say "I do not know" will get inferences presented as facts instead, which is strictly worse.

The four over-claims worth naming

Dropping the scope. "India is ML3" in place of "India's authority is benchmarked at maturity level 3 for vaccines as a producing country, first assessed 2017 and reassessed 2024." The short version implies a general designation that does not exist.

Upgrading the source. Describing a consultancy summary's content as though it came from the instrument. The claim may be correct; the provenance stated is false, and the falsity is what does the damage.

Generalizing the region. Verifying one country and describing its neighbors in the same terms. This is the most common and the most confidently made.

Aging without a date. Repeating a verified claim years later without noting when it was verified. It was true. Whether it is true is a different question that the statement no longer allows the reader to ask.

Where the honesty pays

It reads as weakness and it is the opposite, for a reason worth understanding rather than just believing.

A reviewer's central problem is that they cannot check everything you tell them. They must decide how much of your account to accept on trust. Every signal you give them about your own limits is evidence about how you behave when nobody is checking, and that is precisely what they are trying to determine.

An organization that volunteers the boundary of its knowledge is telling them something they cannot get any other way. An organization whose every claim is maximally confident gives them nothing to calibrate against, so they must assume the worst about the claims they cannot verify.

This is why CRLN's own published standard states in every release that its crosswalks are provisional pending independent review, that 45 of 200 jurisdictions are verified against primary sources, and that no assessment item has been independently attested. Those sentences cost something at first reading. They are also the reason a reader can believe the rest.

In practice

A regulatory lead is asked to sign off marketing copy describing the organization's regulatory coverage as "verified across 200 jurisdictions."

She does not, and the objection is precise. 45 are verified against named primary instruments. 155 carry the baseline as an inference. "Verified across 200" is false about 155 of them.

The proposed replacement is "45 jurisdictions verified against named primary instruments; 200 mapped to a governing regime." Two numbers instead of one, both true, with the stronger claim attached to the smaller number where it belongs.

Marketing objects that it is less impressive. She agrees that it is, and points out the actual risk: the first person to ask "which 200 did you verify, and against what?" gets an answer that contradicts the copy, and that person is usually the regulatory director of the partner you most want.

What this looks like when it goes wrong

A sponsor's capability deck states that its team has "experience across all major regulatory jurisdictions."

In a partnership meeting, the counterpart's regulatory director asks a specific question about one of those jurisdictions: the compensation provisions under India's 2019 Rules.

Nobody in the room knows. The honest answer is that the team has worked in India once, four years ago, under the same framework, and did not handle compensation because the partner did.

The meeting does not end over India. It ends over the deck, because the director now has to assume that every other claim in it was written to the same standard, and she has no way to tell which ones were not.

Key takeaways